New research led by UCL and Great Ormond Street Hospital (GOSH) to predict which childhood leukemia patients are at higher risk of not responding well to chemotherapy could allow clinicians to refine treatment strategies ...
May 5, 2023
0
6
A National Institutes of Health team has identified a compound already approved by the U.S. Food and Drug Administration that keeps light-sensitive photoreceptors alive in three models of Leber congenital amaurosis type 10 ...
Mar 29, 2023
0
7
A new mathematical model which aims to optimize treatment for prostate cancer has been developed by experts at the University of Portsmouth.
Mar 1, 2023
0
1
Investigators have identified new genetic variations effecting gene expression in the liver cells of patients of African ancestry, findings that provide insight into how drugs are metabolized differently in different populations, ...
Feb 8, 2023
0
6
Brain arteriovenous malformation (AVM) is the abnormal entanglement of arteries and veins in the brain, which disrupts the normal flow of blood and can lead to hemorrhage, seizures, and neurological impairment in affected ...
Jan 9, 2023
0
25
The use of circulating tumor cell (CTC) count to guide the choice between chemotherapy and endocrine therapy as first-line therapy for patients with metastatic, estrogen receptor (ER)-positive/HER2-negative breast cancer ...
Dec 8, 2022
0
2
Researchers at Queen's University Belfast have designed a new bandage treatment, known as a scaffold, to treat diabetic foot ulcers, which is cost-effective while improving patient outcomes. Produced by 3D bioprinting, the ...
Oct 7, 2022
0
10
Scientists from The Tisch Cancer Institute have uncovered a mechanism by which certain breast cancer cells regulate their own metastases, fuel dissemination from the original tumor site, and determine routes to invade distant ...
Sep 20, 2022
0
8
Lung cancer is the most common cancer in the world, with 2.2 million new cases and around 1.8 million deaths in 2020 alone. Although knowledge about the disease has improved considerably, and new therapeutic strategies can ...
Jul 5, 2022
0
10
A treatment strategy using an antibody that inhibits a cell signaling protein called interleukin-11 (IL-11) could lead to new hope for people with a debilitating genetic kidney disease called Alport syndrome. Scientists from ...
Mar 9, 2022
0
1
